期刊文献+

痛风胶囊对IgA肾病合并高尿酸血症大鼠肾组织血管内皮生长因子表达的影响 被引量:1

Experimental study on Tongfeng capsules treating IgA nephrophathy with hyperuricaemia and vascular endothelial growth factor expression in renal tissue
下载PDF
导出
摘要 目的:观察痛风胶囊对IgA肾病合并高尿酸血症血管内皮生长因子(VEGF)在肾组织表达的影响。方法:通过建立IgA肾病高尿酸血症的动物模型,同时给予痛风胶囊治疗,分别在第71、78、85、92、99天测24h尿蛋白定量,102d后检测血尿酸、血肌酐、血尿素氮、HE染色制片,光镜观察病理切片及采用免疫组化测定VEGF在肾组织的表达。结果:用药中、后期,治疗组、阳性对照组24h尿蛋白定量均低于模型组(P<0.05);用药后,治疗组、阳性对照组与空白对照组比较血尿酸无明显差异(P>0.05);阳性对照组血肌酐、血尿素氮平均水平明显高于各组(P<0.05);模型组和阳性对照组肾组织中VEGF表达强于空白对照组(P<0.05),治疗组的表达强度与空白对照组之间无显著性差异(P>0.05);阳性对照组肾小管坏死明显,治疗组肾组织结构基本正常。结论:痛风胶囊能降低血尿酸及尿蛋白水平,对肾功能及肾组织结构无损害,能减少VEGF的增生,改善肾血管的完整性。 Objective:studying Tongfeng Capsules intervening IgA nephrophathy with hyperuricaemia and the expression of vascular endothelial growth factor in nephridium, Method: through setting up the animal mould of IgA nephrophathy with hyperuricaemia, using Tongfeng Capsules for treatment, detecting the ration of 24 house' uric protein in 71,78,85,92 and 99 days respectively, after 102 days, detecting uric acid, nrea nitrogen, creatinine and using immunity to detect the expression of vascular endothelial growth factor in nephridium. Result: during metaphase and anaphase when using medicine, treatment and control of the ration of 24 house' uric protein are both under the model ( P 〈 0.05 ) ; After treating , compared with treatment and normal, uric acid is not obviously difference ( P 〉 0.05). compared with control and normal has the significance of statistics( P 〈 0.05 ) ; average of creatinine and nrea nitrogen in control is obviously higher than others(P 〈 0.05 ) ; the intensity of the expression of vascular endothelial growth factor in nephridium in model and control is higher than normal(P 〈 0.05 ), the intensity of treatment and normal has no obviously difference ( P 〉 0.05 ) ; morphometric analysis showed Allopurinol badly destroy nephron, however, Tongfeng capsules did not do that. Conclusion:Tongfeng Capsules can reduce the level of uric acid and uric protein: do no harm to nephridium; reduce the increasing of vascular endothelial growth factor and improve the integrality of nephridium vas.
出处 《江西中医学院学报》 2008年第3期69-71,共3页 Journal of Jiangxi College of Traditional Chinese Medicine
基金 浙江省中医药管理局科研计划项目(2006c130)
关键词 IGA肾病 高尿酸血症 血管内皮生长因子 IgA nephrophathy Hyperuricaemia Vascular endothelial growth factor
  • 相关文献

参考文献2

二级参考文献10

  • 1邹万忠.《肾脏病理与临床》.第一版[M].长沙:湖南科学技术出版社,1993.58.
  • 2Kitamura H, Shimizu A, Masuda Y, et al. Apoptosis in glomerular endothelial cells during the development of glomerulosclerosis in the remnant kidney model. Exp Nephrol, 1998, 6 (4): 328--336.
  • 3Shimizu A, Kitamura H, Masuda Y, et al. Rare glomerular capillary regeneration with endothelial apoptosis in progressive glomerulonephritis. Am J Phthol, 1997,151 (5): 1231--1239.
  • 4Ferrara N, Davissmyth. The biology of vascular endothelial growth factor. Endocrine Rev, 1997, 189 (1):4--25.
  • 5Brown LF, Berse B, Tognazzi K, et al. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int, 1992, 42 (6): 1457--1462.
  • 6Simon M, Rockl W, Homing C , et al. Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney:localization and ^[1-125]VEGF binding site. J Am Soc Nephrol, 1998, 9 (6): 1032--1044.
  • 7Bailey E, Bottomley MJ, Westwel S, et al. Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridization. J Clin Pathol, 1999, 52 (10): 735--738.
  • 8Amemiya T, Sasamura H, Mifune M, et al. Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells.Kidney Int, 1999, 56 (6): 2055--2063.
  • 9王建中,陈香美,师锁柱,张燕平.Ⅰ型纤溶酶原激活物抑制物在IgA肾病肾小管间质损伤中的作用研究[J].中华肾脏病杂志,2000,16(1):11-15. 被引量:32
  • 10王建中,陈香美,师锁柱,张燕平,田月.基质金属蛋白酶-9和金属蛋白酶组织抑制物-1在IgA肾病肾组织中的表达[J].中华内科杂志,2002,41(2):75-78. 被引量:48

共引文献4

同被引文献33

  • 1孙瑞霞,李长贵,苗志敏.人肾脏尿酸盐转运的分子机制研究进展[J].国外医学(泌尿系统分册),2005,25(2):281-285. 被引量:11
  • 2邱强,陈香美,谢院生,魏日胞,吴镝,蔡广研,刘述文.影响IgA肾病高尿酸血症的因素[J].中国中西医结合肾病杂志,2005,6(6):329-331. 被引量:43
  • 3Steele TH.Hyperuricemic nephropathies.Nephron,1999,81(suppl 1):45-49.
  • 4Feiner HD,Cabili S,Baldwin DS,et al.Intrarenal vascular sclerosis in IgA nephropathy.Clin Nephrol,1982,18(4):183-192.
  • 5Wu J,Chen X,Xie Y,et al.Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy.Nephpol Dial Transplant,2005,20(4):719-727.
  • 6Johnson RJ,Schreiner GF.The role of acquired tubuloterstial disease in the paphogenesis of salt dependent hypertension.Kidney Int,1997,52(5):1169-1179.
  • 7Tinahones JF,Perez Lindon G,Soriguer FJ,et al.Dietary alterations in plasma very low density lipoprotein levels modify renal excretion of urates in hyperuricemic-hypertriglyceridemic patients.J Clin Endocrinol Metab,1997,82(4):1188-1191.
  • 8Kanellis J,Watanabe S,Li JH,et al.Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2.Hypertension,2003,41(6):1287-1293.
  • 9Sánchez-Lozada LG,Tapia E,Santamaría J,et al.Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats.Kidney Int,2005,67(1):237-247.
  • 10Myllym(a)ki J,Honkanen T,Syrjnen J,et al.Uric acid correlates with the severity of histopathological parameters in IgA nephropathy.Nephrol Dial Transplant,2005,20(1):89-95.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部